Mirza Ismail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
Mirza Ismail Baig, Clinical Intern and Physician Assistant at CARE Hospitals, Quality CARE India Limited, shared a post on LinkedIn:
“Silent but Significant: The Clinical Importance of Pulmonary Embolism
Pulmonary embolism (PE) remains one of the most potentially fatal yet frequently underrecognized cardiovascular emergencies.
The condition occurs when a thrombus, most commonly originating from the deep veins of the lower extremities, embolizes to the pulmonary circulation and obstructs blood flow.
Common risk factors include:
- Prolonged immobilization
- Recent surgery
- Malignancy
- Pregnancy and postpartum state
- Previous venous thromboembolism
- Inherited thrombophilia
Clinical presentation can vary widely, ranging from mild dyspnea to sudden hemodynamic collapse.
Key findings may include:
- Acute onset shortness of breath
- Pleuritic chest pain
- Tachycardia
- Hypoxemia
- Syncope in severe cases
One of the most important lessons in clinical medicine is that a normal chest X-ray does not exclude a life-threatening diagnosis.
Diagnostic evaluation often relies on:
- D-dimer testing
- CT Pulmonary Angiography (CTPA)
- Echocardiography in unstable patients
- Clinical prediction tools such as the Wells Score
Early anticoagulation with agents such as:
- Enoxaparin
- Unfractionated Heparin
- Apixaban
- Rivaroxaban
can significantly improve outcomes when initiated promptly.
Pulmonary embolism serves as a reminder that not every patient with acute breathlessness has a primary respiratory disease—sometimes the pathology lies within the pulmonary vasculature itself.”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 04:43Tom Tang: Preventing Post Thrombotic Syndrome Starts With Early DVT Prevention
-
Sep 17, 2026, 04:35Veronica Sanchez: Menopause as a Risk for Heart Disaese
-
Sep 17, 2026, 03:20Jessica Frye: Understanding VTE in Pregnancy and the Postpartum Period
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
-
Sep 17, 2026, 02:36Wolfgang Miesbach: Effectiveness of Avatrombopag in ITP Treatment
-
Sep 17, 2026, 02:34Aleksandar Sič: The Endothelium and Cardiovascular Toxicity in Blood Cancers
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?